sector medic suppli devic
messag turn solid sale top consensu
ep beat vast major earn upsid driven
lower expect tax rate vs tax fx respons
manag ep guidanc revis well absent item
busi continu perform high level csi post pro
forma growth share trade revis ntm ep estim
howev see stock fulli valu current level maintain neutral
solid tax benefit overst bottom line perform
revenu pro forma top consensu adjust ep
yoy came ahead street expect without benefit
lower interest tax expens howev estim ep would
consensu also worth note street expect much higher
month ago manag talk earn due initi forecast
signific step tax rate guidanc said time seem like prove
conserv said view underli revenu growth
csi strong perform particularli latter given fact paragard came
light forecast
much tax headwind guidanc head higher full year revenu
expect come previous underli
growth still peg meanwhil adjust ep project
vs increas midpoint
attribut improv oper perform howev remaind split
lower tax interest expens note street consensu
sat go last quarter call recalibr tax headwind
longer appear forthcom currenc also track less headwind
look like would back decemb ad increment ep
growth compani continu invest key account strategi within
increas promot spend drive paragard adopt
turn back quarter coopervis sale pro forma came
consensu growth mark sequenti deceler
quarter perform come yoy comp tougher
categori perspect upsid driven primarili out-performance single-
use sphere cc toric cc came
street respect elsewher multifoc cc
essenti line consensu non single-us sphere cc beat
driven strength asia pacif cc emea cc meanwhil america
growth cc sequenti estim silicon hydrogel len
sale rose forecast driven continu momentum
daili sih franchis cc meanwhil perform extend wear
sih brand held steadi sequenti biofin avaira combin grow cc
manag rais revenu guidanc form
underli basi growth forecast bottom
rang model call coopervis revenu come
continu page
page analyst certif import disclosur
estim global contact len sale rose cc calendar line
gain first half year overal four
major manufactur combin sale report basi
ex-fx repres notabl acceler constant currenc gain
cooper share increas sequenti compar
bausch also took share quarter sequenti yoy
 js perform mix sequenti yoy alcon cede
ground sequenti yoy overal contact len market remain
healthi despit growth moder margin out-performance
widen narrow earlier year compani trail
underli growth rate stand vs competitor see figur
see world-wide contact len growth slow would
repres deceler gain still toward high end cooper
posit benefit daili len adopt increas silicon hydrogel penetr
model call compani remain net share taker increas
daili sih competit dynam keep eye move forward howev
bausch alcon pois roll new product segment next
month extent alcon drive acceler contact len growth
particular interest compani pois make return
public market biggest laggard space
past year see figur
compani report guggenheim secur llc estim
compani report guggenheim secur llc estim
turn coopersurg revenu pro forma top
consensu paragard weaker expect quarter sale
came forecast despit easi comp compani lap
inventori issu manag still expect paragard grow mid-singl
digit clip go forward conserv forecast view especi given addit
promot spend alloc product meanwhil financi impact
paragard appar quarter csi gross margin jump yoy
elsewher base offic surgic product busi pro forma turn
solid perform fertil segment pro forma rebound
difficult fiscal manag slightli rais guidanc csi sale
underli growth still peg model
call coopersurg revenu pro forma
page analyst certif import disclosur
top line tax lower interest/oth expens drove major
bottom line beat fiscal gross margin flat yoy
consensu sg spend rose yoy sale came
street expect meanwhil spend grew yoy sale
higher consensu collect result fiscal ebita margin
yoy street estim bottom line adjust ep
came higher consensu due primarili lower
expect tax rate vs consensu lower interest/oth expens
cooper oper expens grown faster sale seven past nine
quarter reach level manag signal
compani pull forward paragard promot spend
expect trend continu manag call adjust ep
yoy vs consensu come week due larg part
acceler pace invest
current level believ solid top line momentum fulli reflect
stock especi given sluggish earn growth model call
compani post ep total revenu
pro forma previous meanwhil earn
estim stay virtual unchang manag expect
return normal tax rate occur next year backdrop
share trade revis ntm ep estim premium large-
cap med-tech averag solid top line growth rate vs
large-cap group would seem argu premium valuat compani
earn growth appear like lag behind group averag least
next two year also view cooper outsiz exposur currenc swing rise
interest rate consum categori believ could prove highli cyclic
next econom downturn argument multipl expans result
maintain neutral rate
page analyst certif import disclosur
straddl line healthcar consum product contact
len women health busi coopervis portfolio uniqu posit take
advantag two tailwind drive contact len market growth today shift
premium len materi particular silicon hydrogel increas popular
daili dispos lens recent year leverag broadest daili sih
offer market lead posit monthli sih categori continu
long histori above-market growth compani captur averag
market share per year sinc expect gain moder go forward
backdrop competit contact len market believ cooper
remain well posit sustain growth
elsewher paragard deal add scale coopersurg grow women health
presenc often overlook investor expect csi account
overal revenu growth fuel
primarili compani invest half dozen deal
build lead posit ivf genet test market follow recent
acquisit paragard intrauterin devic believ long-term
fundament market appeal see grow scale csi neg
broader invest case complic stori believ
investor would prefer look sole contact len play
share current trade ntm ep ntm ebitda
repres premium large-cap med-tech group averag price-to-earnings
large-cap group would seem argu slight premium valuat dont
see compani sustain bottom line growth trajectori meaning differenti
group averag also view cooper outsiz exposur
currenc swing rise interest rate consum categori believ could
prove highli cyclic next econom downturn argument multipl
expans result maintain neutral rate
upsid risk rate includ faster expect contact len market growth due
rise sih penetr daili len adopt increas share gain
busi better expect growth/accret paragard
downsid risk rate includ better anticip traction competit
contact len launch weaken macroeconom backdrop put pressur
cooper busi see discretionari med-tech market
potenti exposur strong dollar rise interest rate
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
